Release of FITC-BSA from poly(l-lactic acid) microspheres analysis using flow cytometry
Source abstract
Abstract
In this investigation, biodegradable polymer poly(L-lactic acid) (PLA) microspheres were prepared by the W(1)/O/W(2) solvent evaporation method. The inner phase was aqueous solution (W(1)) that contained bovine serum albumin that was labeled with fluorescein isothiocyanate (FITC-BSA). PLA was dissolved in chloroform with emulsifier sorbitan monooleate (span 80) as the dispersed phase (O). These two solutions (W(1)/O) were emulsified by a homogenizer to form a primary emulsion. Polyvinyl alcohol (PVA) used as surfactant, was applied in the formation of microspheres (W(2)). 0.5% (w/v) PLA was stirred at 3000 rpm using a homogenizer. Microspheres with sizes of up to around 10 μm were produced. These microspheres were separated by the glycerol gradient method, and take microspheres at part of 25% glycerol gradient concentration was analyzed by flow cytometry, indicating a more homogeneous particle size distribution than that not separated. The microspheres were degraded using several enzymes, and around 40% was degraded by 72 h. This result reveals the effectiveness of drug delivery by PLA microspheres, which was evaluated by performing a drug release test and flow cytometric analysis. The FITC-BSA concentration in the supernatant increased with the experimental time. At the phagocytosis experiments, encapsulated with FITC-BSA drug of microspheres can be used by the cell, as particle size approximately 1 μm.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · biodegradable polymer synthesis and properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (18)
Show source-provided references
1. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres10.1023/A:1015841715384 ↗
2. 1999 · 816
3. Uniform encapsulation of stable protein nanoparticles produced by spray freezing for the reduction of burst release10.1002/jps.20209 ↗
4. Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients10.1016/S0939-6411(96)00017-3 ↗
5. Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique10.1016/S0168-3659(02)00494-7 ↗
6. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres10.1023/A:1014818118224 ↗
7. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes10.1016/S0168-3659(00)00224-8 ↗
8. preparation of insulin-loaded PLA/PLGA microcapsules by a novel membrane emulsification method and its release in vitro10.1016/j.colsurfb.2006.05.014 ↗
9. Preparation of poly(β-hydroxybutyrate) and poly(lactide) hollow spheres with controlled wall thickness10.1016/j.polymer.2006.09.058 ↗
10. Degradation and release profile of microcapsules made of poly[l-lactic acid-co-l-lysine(Z)]10.1016/S0168-3659(98)00012-1 ↗
11. Preparation and characterization of poly(lactic acid)–poly(ethylene glycol)–poly(lactic acid) (PLA–PEG–PLA) microspheres for controlled release of paclitaxel10.1016/S0142-9612(03)00419-8 ↗
12. Influence of process parameters on the size distribution of PLA microcapsules prepared by combining membrane emulsification technique and double emulsion-solvent evaporation method10.1016/j.colsurfb.2005.08.004 ↗
13. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique10.1016/j.jcis.2003.08.067 ↗
14. Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres10.1016/j.jconrel.2004.08.006 ↗
15. BSA-FITC-loaded microcapsules for in vivo delivery10.1016/j.biomaterials.2008.10.030 ↗
16. Facile preparation of fluorescence-encoded microspheres based on microfluidic system10.1016/j.jcis.2010.08.042 ↗
17. Microfluidic preparation of monodisperse ethyl cellulose hollow microcapsules with non-toxic solvent10.1016/j.jcis.2009.03.050 ↗
18. Droplet-based microfluidic platforms for single T cell secretion analysis of IL-10 cytokine10.1016/j.bios.2010.09.006 ↗